Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Bile Duct Neoplasms × Immunotherapy × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 4 Squamous Cell Carcinoma of Head and Neck 2 Neoplasms 2 Melanoma 2 Lung Neoplasms 2 Sarcoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Multiple Myeloma 1 Mesothelioma, Malignant 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Histiocytosis 1 Head and Neck Neoplasms 1 Glioblastoma 1 Cholangiocarcinoma 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Brain Neoplasms 1 Anemia, Refractory, with Excess of Blasts 1

Interventions

Gemcitabine 12 Capecitabine 8 Cisplatin 7 pembrolizumab 4 Fluorouracil 4 Sorafenib 3 Oxaliplatin 3 Erlotinib Hydrochloride 3 trametinib 2 regorafenib 2 N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 2 Leucovorin 2 Lapatinib 2 trifluridine tipiracil drug combination 1 tremelimumab 1 spartalizumab 1 seribantumab 1 olutasidenib 1 durvalumab 1 devimistat 1 derazantinib 1 dehydroftorafur 1 cediranib 1 cabozantinib 1 Trifluridine 1 Trastuzumab 1 Therapeutics 1 Sutures 1 Surgical Instruments 1 Standard of Care 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡